Rare lephants
Screener

Dermata Therapeutics, Inc.

DRMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q May 15, 2024 FORM 10-Q
8-K May 15, 2024 FORM 8-K
8-K May 15, 2024 FORM 8-K
8-K May 14, 2024 FORM 8-K
8-K May 7, 2024 FORM 8-K
ARS Mar 26, 2024 ARS
DEFA14A Mar 26, 2024 DEFA 14A
DEF 14A Mar 26, 2024 DEF 14A
10-K Mar 21, 2024 FORM 10-K
8-K Mar 21, 2024 FORM 8-K
PRE 14A Mar 4, 2024 PRE 14A
SC 13G Feb 14, 2024
8-K Jan 12, 2024 FORM 8-K
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 FORM 4
4 Jan 5, 2024 PRIMARY DOCUMENT
4 Jan 5, 2024 PRIMARY DOCUMENT
4 Jan 5, 2024 PRIMARY DOCUMENT
4 Jan 5, 2024 PRIMARY DOCUMENT
4 Jan 5, 2024 PRIMARY DOCUMENT
4 Jan 5, 2024 FORM 4
EFFECT Dec 15, 2023
← Newer Page 7 of 15 · 366 filings Older →